Patent classifications
C12Q2334/22
SAPOSIN C PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CANCER
Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
Culture medium for detection of bacterium belonging to genus <i>Listeria</i>
A medium containing (A) a chromogenic substance which develops a color when decomposed by β-glucosidase or a fluorogenic substance which develops a fluorescence when decomposed by β-glucosidase; (B) a chromogenic substance which develops a color when decomposed by phosphatidyl inositol-specific phospholipase C or a fluorogenic substance which develops a fluorescence when decomposed by phosphatidyl inositol-specific phospholipase C; and (C) a sugar that is useful for the detection of Listeria monocytogenes and/or Listeria ivanovii.
Saposin C pharmaceutical compositions and methods of treating cancer
Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers. Also disclosed are methods for assaying potency of a test composition comprising saposin C and an anionic phospholipid.
Fluorescence based extracellular enzyme activity assay for early detection of biofouling in seawater desalination systems
A method and system for early detection of biofouling utilizing a fluorescence based extracellular enzyme activity assay is disclosed. The method provides a means for early detection of biofouling on membranes used in flow-through membrane filtration systems for with a feed water flow, such as waste water of water for desalination. Also disclosed is an at-line sensor utilizing the fluorescence based extracellular enzyme activity assay that is positioned in the membrane filtration system for detection of biofouling.
Method and kit for detecting pathogenic microorganism
Provided is a method for detecting pathogenic microorganisms in a biological sample, which is a technique that can be used to perform high-sensitivity detection of pathogenic microorganisms, such as influenza virus, etc.
CULTURE MEDIUM FOR DETECTION OF BACTERIUM BELONGING TO GENUS LISTERIA
Provided is means for detecting Listeria monocytogenes and/or Listeria ivanovii in a simple and specific manner. A culture medium for detection of Listeria monocytogenes and/or Listeria ivanovii, provided containing the following components (A), (B), and (C): (A) a chromogenic substance which develops a color when decomposed by -glucosidase or a fluorogenic substance which develops a fluorescence when decomposed by -glucosidase; (B) a chromogenic substance which develops a color when decomposed by phosphatidyl inositol-specific phospholipase C or a fluorogenic substance which develops a fluorescence when decomposed by phosphatidyl inositol-specific phospholipase C; and (C) a sugar.
SAPOSIN C PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CANCER
Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
Saposin C pharmaceutical compositions and methods of treating cancer
Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.
FLUORESCENCE BASED EXTRACELLULAR ENZYME ACTIVITY ASSAY FOR EARLY DETECTION OF BIOFOULING IN SEAWATER DESALINATION SYSTEMS
A method and system for early detection of biofouling utilizing a fluorescence based extracellular enzyme activity assay is disclosed. The method provides a means for early detection of biofouling on membranes used in flow-through membrane filtration systems for with a feed water flow, such as waste water of water for desalination. Also disclosed is an at-line sensor utilizing the fluorescence based extracellular enzyme activity assay that is positioned in the membrane filtration system for detection of biofouling.
SAPOSIN C PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING CANCER
Disclosed are pharmaceutical compositions containing saposin C and phosphatidylserine that are useful for treating various cancers.